Similarly, we observed an increased frequency of TIGIT+ cells in both CD4 and CD8 TILs when compared with T cells in peripheral blood from lung, cervical, gastric, and colorectal cancer patients; breast and esophageal cancer patients showed a similar trend, but it was not statistically significant (Supplementary Figures 2E,F). This evidence concerns the gene CD4 and esophageal cancer.